Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID‐19

Apaydin et al., Clinical Endocrinology, doi:10.1111/cen.14664
Dec 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,100+ studies for 60+ treatments. c19early.org
Analysis of 297 hospitalized COVID-19 patients in Turkey, showing no significant association between vitamin D levels and severity, ICU admission, or mortality. VDR gene polymorphisms were independently associated with COVID-19 severity and mortality.
Apaydin et al., 25 Dec 2021, Turkey, peer-reviewed, 15 authors, study period April 2020 - October 2020. Contact: tugceapaydin88@hotmail.com, hamzapolatdr@gmail.com, dincer.ceyda@gmail.com, can.ilgin@hotmail.com, dronurelbasan@hotmail.com, drsaida90@gmail.com, bayramfeyza1@gmail.com, fetukenmez@yahoo.com, ozanunlu_57@hotmail.com, ahmetfaruk.aft@gmail.com, arslanebruuu@hotmail.com, ipekyilmaz044@gmail.com, goncahaklar@marmara.edu.tr, pinaren@gmail.com, hulyagozu@yahoo.com.
This PaperVitamin DAll
Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID‐19
MD Tugce Apaydin, MD Hamza Polat, Ceyda Dincer Yazan, MD Can Ilgin, MD Onur Elbasan, MD Saida Dashdamirova, Feyza Bayram, MD Elif Tukenmez Tigen, MD Ozan Unlu, MD Ahmet F Tekin, Ebru Arslan, Ipek Yilmaz, MD Goncagul Haklar, Pınar Ata, MD Hulya Gozu
Clinical Endocrinology, doi:10.1111/cen.14664
Purpose: Vitamin D deficiency has emerged as another potential risk factor for coronavirus disease (COVID-19) due to the immunomodulatory effects of 25 hydroxyvitamin D [25 (OH)D]. Vitamin D receptor (VDR) gene polymorphisms such as Fok I, Bsm I, Apa I, and Taq I are also associated with different courses of viral infections. This study aimed to evaluate the association between the VDR gene polymorphism at Fok I, Taq I, Bsm I, and Apa I genotypes and the prognosis of COVID-19 in respect to vitamin D deficiency. Methods: Two-hundred ninety-seven patients with COVID-19 were enrolled. Serum 25 (OH)D levels were measured. Four variant regions of the VDR gene, FokI, BsmI, ApaI, and TaqI were determined.
Conflict of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. Author contribution statement: All authors made substantial contributions to conception and design, and acquisition of data, and analysis and interpretation of data; participated in drafting the article or revising it critically for important intellectual content, and final approval of the version to be submitted. Ethical Approval: All procedures performed in studies involving human participants followed the institutional research committee's ethical standards, the 1964 Helsinki declaration, and its later amendments or comparable ethical standards. Informed consent: Informed consent was obtained from all participants included in the study. Abbreviations This article is protected by copyright. All rights reserved. Accepted
References
Abdollahzadeh, Shushizadeh, Barazandehrokh, Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients, Infect Genet Evol
Ali, Role of vitamin D in preventing of COVID-19 infection, progression and severity, J Infect Public Health
Alpdemir, Alpdemir, Vitamin D deficiency status in Turkey: A metaanalysis, International Journal of Medical Laboratory
Annweiler, Hanotte, De L'eprevier, Sabatier, Lafaie et al., Vitamin D and survival in COVID-19 patients: A quasiexperimental study, J Steroid Biochem Mol Biol
Bilezikian, Bikle, Hewison, MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19, Eur J Endocrinol
Binkley, Ramamurthy, Krueger, Low vitamin D status: definition, prevalence, consequences, and correction, Endocrinol Metab Clin North Am
Bivona, Agnello, Bellia, Non-Skeletal Activities of Vitamin D: From Physiology to Brain Pathology, Medicina (Kaunas)
Bivona, Agnello, Ciaccio, Biomarkers for Prognosis and Treatment Response in COVID-19 Patients, Ann Lab Med
Bivona, Agnello, Ciaccio, The immunological implication of the new vitamin D metabolism, Cent Eur J Immunol
Bivona, Agnello, Ciaccio, Vitamin D and Immunomodulation: Is It Time to Change the Reference Values? Annals of clinical and laboratory science
Butler-Laporte, Nakanishi, Mooser, Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study, PLoS Med
Campi, Gennari, Merlotti, Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy, BMC Infect Dis
Carpagnano, Lecce, Quaranta, Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J Endocrinol Invest
Ciaccio, Agnello, Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19), Diagnosis (Berl)
Cousin, Giraud, Bendjelid, Pathophysiology of COVID-19: Everywhere You Look You Will See ACE2!, Front Med
Daneshkhah, Eshein, Subramanian, Roy, Backman, The Role of Vitamin D in Suppressing Cytokine Storm in COVID-19 Patients and Associated Mortality, medRxiv
Darling, Ahmadi, Ward, Vitamin D status, body mass index, ethnicity and COVID-19: Initial analysis of the first-reported UK Biobank COVID-19 positive cases (<em>n</em> 580) compared with negative controls
Hastie, Mackay, Ho, Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr
Hernandez, Nan, Fernandez-Ayala, Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection, J Clin Endocrinol Metab
Hoan, Khuyen, Giang, Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus, BMC Med Genet
Holick, Binkley, Bischoff-Ferrari, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab
Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res
Laird, Rhodes, Kenny, Vitamin D and Inflammation: Potential Implications for Severity of Covid-19, Ir Med J
Laplana, Royo, Fibla, Vitamin D Receptor polymorphisms and risk of enveloped virus infection: A meta-analysis, Gene
Lewis, Baker, Smith, Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk, Int J Tuberc Lung Dis
Liu, Wang, Shi, Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis, Postgrad Med J
Mathyssen, Gayan-Ramirez, Bouillon, Janssens, Vitamin D supplementation in respiratory diseases: evidence from randomized controlled trials, Pol Arch Intern Med
Mcdonnell, Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients
Mcnally, Sampson, Matheson, Hutton, Little, Vitamin D receptor (VDR) polymorphisms and severe RSV bronchiolitis: a systematic review and meta-analysis, Pediatr Pulmonol
Merzon, Tworowski, Gorohovski, Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study, FEBS J
Munshi, Hussein, Toraih, Vitamin D insufficiency as a potential culprit in critical COVID-19 patients, J Med Virol
Murai, Fernandes, Sales, Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial, JAMA
Ogunkolade, Boucher, Prahl, Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians, Diabetes
Patchen, Clark, Hancock, Gaddis, Cassano, Genetically predicted serum vitamin D and COVID-19: a Mendelian randomization study, medRxiv
Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger, Vitamin D Deficiency and Outcome of COVID-19 Patients, Nutrients
Roth, Jones, Prosser, Robinson, Vohra, Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood, J Infect Dis
Shi, Liu, Yao, Chronic vitamin D deficiency induces lung fibrosis through activation of the renin-angiotensin system, Sci Rep
Smet, Smet, Herroelen, Gryspeerdt, Martens, Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics, medRxiv
Triantos, Aggeletopoulou, Kalafateli, Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis, Sci Rep
Uitterlinden, Fang, Van Meurs, Pols, Leeuwen et al., Nutritional Modulation of Immune Function: Analysis of Evidence, Mechanisms, and Clinical Relevance, Front Immunol
Whowgotc, Management of C-i. A minimal common outcome measure set for COVID-19 clinical research, Lancet Infect Dis
Youssef, Ranasinghe, Grant, Peiris, Vitamin D's potential to reduce the risk of hospital-acquired infections, Dermatoendocrinol
Zacharioudaki, Messaritakis, Galanakis, Vitamin D receptor, vitamin D binding protein and CYP27B1 single nucleotide polymorphisms and susceptibility to viral infections in infants, Sci Rep
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit